About EMKinetics
EMKinetics is a Healthcare company based in San Francisco (United States) founded in 2006. Transdermal stimulation therapy is provided for urinary incontinence treatment. EMKinetics has raised $12.53 million across 6 funding rounds. Its focus areas include Life Sciences, Genitourinary Disorders, Medical Devices and Therapeutics. Its competitors include Amphora Medical, Cogentix Medical and Valencia Technologies; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2006 and based in San Francisco, United States, EMKinetics operates in the medical technology sector. Neuromodulation therapies are developed using TranStim, a transdermal stimulation technology. This approach targets the posterior tibial nerve to reduce urinary bladder overactivity and address urinary incontinence. Clinical-stage operations focus on preventive treatments for bladder-related conditions.
- Headquarters San Francisco, United States
- SectorsHealthcare
- Email••••••••
- Website emkinetics.com
- Social LinkedIn
- Total Equity Funding$12.53M (USD)
in 6 rounds
- Latest Funding Round$250K (USD), Series B
Feb 2014
Funding Insights of EMKinetics
EMKinetics has successfully raised a total of $12.53M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $250 thousand completed in February 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $12.53M
- Total Rounds 6
- Last Round Series B — $250,000
- First Round $500,000
(Sep 2008)
All 6 funding rounds of EMKinetics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2014 | $250,000 | Series B | – | – | – |
| Jul 2011 | $8M | Series B | – | – | – |
| Jun 2011 | $182,624 | Series A | – | – | – |
| Sep 2010 | $3.44M | Series A | – | – | – |
| Jun 2009 | $158,962 | Seed | – | – | – |
| Sep 2008 | $500,000 | Seed | – | – | – |
People of EMKinetics
1 people are tracked at EMKinetics (1 in leadership).
| Name | Role | Group |
|---|---|---|
Daniel Burnett | Founder / CTO | Leadership |
Complete people profiles for EMKinetics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of EMKinetics
3 dated milestones of EMKinetics across 8 years, from founding to its latest funding, stage changes and deals.
- Founded EMKinetics is founded.
- Funding First funding round of $500K.
- Funding Latest funding round, Series B, of $250K.
Competitors of EMKinetics
EMKinetics has 3 listed competitors in our database, 3 of them funded. They include Amphora Medical, Cogentix Medical and Valencia Technologies.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amphoramedical.com | 2011 | Minneapolis, United States | $48.28M | 12 | Radiofrequency ablation device for overactive bladder treatment | |
| cogentixmedical.com | 1987 | Orangeburg, United States | $25M | 141 | Minimally invasive treatment of voiding dysfunctions and endoscopy solution | |
| valenciatechnologies.com | 2011 | Santa Clarita, United States | $54.97M | A coin-sized neuromodulation device for hypertension treatment is developed. |
Detailed competitors of EMKinetics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genitourinary Disorders
3 companies that operate in the same segment as EMKinetics (Genitourinary Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | |||
Provider of surgical devices for vertical hernia repair and abdominal wall reconstruction | 2012 | Malvern, Pennsylvania, United States | USD 104.6 M | USD 80.28 M | 209 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about EMKinetics
EMKinetics was founded in 2006 and raised its 1st funding round 2 years after it was founded.
EMKinetics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
EMKinetics is a funded company, having raised a total of $12.53M across 6 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on Sep 2008.
Founded in 2006 and based in San Francisco, United States, EMKinetics operates in the medical technology sector. Neuromodulation therapies are developed using TranStim, a transdermal stimulation technology. This approach targets the posterior tibial nerve to reduce urinary bladder overactivity and address urinary incontinence. Clinical-stage operations focus on preventive treatments for bladder-related conditions.
EMKinetics's top competitors include Valencia Technologies, Amphora Medical and Cogentix Medical.